Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

BACKGROUND: Prior Studies have suggested better outcomes in smokers compared with nonsmokers receiving clopidogrel (“smoker's paradox”). The impact of a more intensive clopidogrel regimen on ischemic and bleeding risks in smokers with acute coronary syndromes requiring percutaneous coronary int...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Am Heart Assoc
Egile Nagusiak: Bossard, Matthias, Granger, Christopher B., Tanguay, Jean‐Francois, Montalescot, Gilles, Faxon, David P., Jolly, Sanjit S., Widimsky, Petr, Niemela, Kari, Steg, Philippe Gabriel, Natarajan, Madhu K., Gao, Peggy, Fox, Keith A. A., Yusuf, Salim, Mehta, Shamir R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2017
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721756/
https://ncbi.nlm.nih.gov/pubmed/29101117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006577
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak